Cargando cotizaciones...
Previsión
| Comprar |
4 |
| Mantener |
11 |
| Vender |
2 |
Noticias Ir al feed de noticias
Genworth Financial: stock falls after CEO takes medical leave
Shares of Genworth Financial fell 1.9% in after-hours trading after CEO Tom McInerney is taking a temporary leave due to health issues. The board appointed Jerome Upton, the company's CFO, as interim president and CEO with immediate effect; Upton has worked at the company since 1998 and has been CFO since March 2023. The board said the management team is well positioned while Genworth continues to provide its services to support care decisions and long-term care planning. » Más en de.investing.com
Genworth beats earnings expectations in Q1 thanks to strong Enact performance
Genworth reported adjusted operating earnings of $0.28 per share in the first quarter, well ahead of analysts’ expectations, driven by mortgage-insurance subsidiary Enact, which contributed $140 million to results and released reserves. Enact also raised its quarterly dividend and delivered solid PMIERs solvency of 162%. At the same time, the CareScout platform grew strongly (placements +158% year‑over‑year), and Genworth continued capital actions, including $66 million in buybacks and $99 million in capital returns from Enact, with management targeting an additional capital return of around $500 million for 2026. » Más en de.investing.com
Genworth Financial posts $0.02 EPS and misses Q4 2025 by a wide margin
Genworth Financial reported Q4 2025 earnings of $0.02 per share versus $0.11 expected, missing estimates by a wide margin. The company recorded a net income of $2 million; the mortgage-insurance segment Enact contributed an adjusted $146 million, while the closed‑block book—particularly long‑term care—was weighed down by heavy losses. The stock rose 3.55% premarket despite the disappointment. Genworth plans investments in the CareScout platform and is targeting significant growth in its services business in 2026. » Más en de.investing.com
Dividendos históricos Dividendos
Todas las métricas de dividendos Todas las métricasDatos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 1665,68 M | 13,68 % |
| Beneficio bruto | 1665,68 M | 2294,23 % |
| Beneficio neto | 41,18 M | 4,82 % |
| EBITDA | 118,29 M | 7,67 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 3270,26 M € |
Número de acciones | 383,01 M |
Máximo/mínimo de 52 semanas | 8,85 € - 6,75 € |
| Dividendos | No |
Beta | 0,86 |
Ratio P/E | 18,20 |
Ratio PEG | 0,91 |
Ratio P/B | 0,43 |
Ratio P/S | 0,54 |
Perfil de la empresa
Genworth Financial, Inc. bietet Versicherungsprodukte in den Vereinigten Staaten und international an. Das Unternehmen ist in drei Segmenten tätig: Enact, U.S. Life Insurance und Runoff. Das Segment Enact bietet Hypothekenversicherungsprodukte an, die in erster Linie erstklassige, individuell gezeichnete Wohnhypothekendarlehen versichern, sowie Pool-Hypothekenversicherungsprodukte. Das Segment U.S. Life Insurance bietet Pflegeversicherungsprodukte an und betreut traditionelle Lebensversicherungen und festverzinsliche Rentenprodukte in den Vereinigten Staaten. Das Runoff-Segment umfasst variable Rentenversicherungen, variable Lebensversicherungen und unternehmenseigene Lebensversicherungen sowie Finanzierungsvereinbarungen. Das Unternehmen vertreibt seine Produkte über den Außendienst, eigene Vertriebsmitarbeiter und digitale Marketingprogramme. Das Unternehmen wurde 1871 gegründet und hat seinen Hauptsitz in Richmond, Virginia.
| Nombre | Genworth Financial 'A' |
| CEO | Jerome T. Upton |
| Sede | Glen Allen,
va Estados Unidos |
| Sitio web | |
| Sector | Finanzas |
| Industria | Servicios financieros |
| Salida a bolsa | 25/05/2004 |
| Empleados | 3100 |
Deep Dive
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | GNW |
Frankfurt | GGK.F |
Düsseldorf | GGK.DU |
Descubrir activos
Los accionistas de Genworth Financial 'A' también invierten en los siguientes activos


